INST 0601C: A randomized phase II protocol of erlotinib versus standard platinum-based chemotherapy in patients with newly diagnosed, advanced non-small cell carcinoma of the lung.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 20 Aug 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

14 Aug 2015 Status changed from completed to discontinued as per ClinicalTrials.gov record.
25 May 2012 Actual end date changed from 1 Jul 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
29 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com